Insider Trading & Ownership - NewAmsterdam Pharma Co N.V. (NAMS)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for NewAmsterdam Pharma Co N.V.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-12-18
Sale
2024-12-20
4:25 pm
NewAmsterdam Pharma Co N.V.NAMSForGrowth NAP B.V.
Forbion Capital Fund IV Cooperatief U.A.
Forbion IV Management B.V.
Forbion Growth Opportunities Fund I Cooperatief U.A.
Forbion Growth Management B.V.
10% Owner
157,234$25.86$4,066,71410,851,996
(Indirect)
View
2024-12-16
Sale
2024-12-18
4:15 pm
NewAmsterdam Pharma Co N.V.NAMSForGrowth NAP B.V.
Forbion Capital Fund IV Cooperatief U.A.
Forbion IV Management B.V.
Forbion Growth Opportunities Fund I Cooperatief U.A.
Forbion Growth Management B.V.
10% Owner
115,480$25.95$2,996,15611,009,230
(Indirect)
View
2024-12-12
Sale
2024-12-16
4:15 pm
NewAmsterdam Pharma Co N.V.NAMSForGrowth NAP B.V.
Forbion Capital Fund IV Cooperatief U.A.
Forbion IV Management B.V.
Forbion Growth Opportunities Fund I Cooperatief U.A.
Forbion Growth Management B.V.
10% Owner
191,762$25.34$4,859,87511,124,710
(Indirect)
View
2024-12-10
Sale
2024-12-12
4:15 pm
NewAmsterdam Pharma Co N.V.NAMSForGrowth NAP B.V.
Forbion Capital Fund IV Cooperatief U.A.
Forbion IV Management B.V.
Forbion Growth Opportunities Fund I Cooperatief U.A.
Forbion Growth Management B.V.
10% Owner
462,288$25.4$11,740,61811,316,472
(Indirect)
View
2024-11-15
Sale
2024-11-19
4:15 pm
NewAmsterdam Pharma Co N.V.NAMSForGrowth NAP B.V.
Forbion Capital Fund IV Cooperatief U.A.
Forbion IV Management B.V.
Forbion Growth Opportunities Fund I Cooperatief U.A.
Forbion Growth Management B.V.
10% Owner
41,803$25.07$1,047,87611,778,760
(Indirect)
View
2024-11-13
Sale
2024-11-15
4:36 pm
NewAmsterdam Pharma Co N.V.NAMSForGrowth NAP B.V.
Forbion Capital Fund IV Cooperatief U.A.
Forbion IV Management B.V.
Forbion Growth Opportunities Fund I Cooperatief U.A.
Forbion Growth Management B.V.
10% Owner
10,898$25.01$272,51111,820,563
(Indirect)
View
2024-10-01
Sale
2024-10-01
5:23 pm
NewAmsterdam Pharma Co N.V.NAMSKooij Louise Frederika
Chief Accounting Officer
45,000$15.72$707,400168,073
(Direct)
View
2024-09-26
Purchase
2024-09-30
5:22 pm
NewAmsterdam Pharma Co N.V.NAMSAudet Juliette Berangere
Chief Business Officer
1,104$15.7$17,3331,104
(Direct)
View
2024-08-20
Purchase
2024-08-22
4:30 pm
NewAmsterdam Pharma Co N.V.NAMSDavidson Michael H.
Chief Executive Officer
5,000$16.27$81,350818,563
(Indirect
Direct)
View
2024-06-20
Purchase
2024-06-24
08:30 am
NewAmsterdam Pharma Co N.V.NAMSDavidson Michael H.
Chief Executive Officer
5,000$17.26$86,309813,563
(Indirect
Direct)
View
2024-03-26
Purchase
2024-03-28
4:30 pm
NewAmsterdam Pharma Co N.V.NAMSTopper James N
Director
8,429$21.5$181,2246,809,429
(Indirect)
View
2024-03-26
Sale
2024-03-27
4:30 pm
NewAmsterdam Pharma Co N.V.NAMSKastelein Johannes Jacob Pieter
Chief Scientific Officer
190,476$21.5$4,095,234970,229
(Indirect)
View
2024-02-13
Purchase
2024-02-21
5:00 pm
NewAmsterdam Pharma Co N.V.NAMSLANGE LOUIS G
Director
5,000$19$95,00024,878
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-10-09
Gift
2024-10-11
5:01 pm
2022-12-22
2027-11-23
NewAmsterdam Pharma Co N.V.NAMSDavidson Michael H.
Chief Executive Officer
15,000$11.585,000
(Direct)
View
2024-09-27
Exercise
2024-10-01
5:23 pm
N/A
2031-07-06
NewAmsterdam Pharma Co N.V.NAMSKooij Louise Frederika
Chief Accounting Officer
45,000$0168,073
(Direct)
View
2024-07-17
Option Award
2024-07-19
4:31 pm
N/A
2034-07-17
NewAmsterdam Pharma Co N.V.NAMSMcKenna Mark C.
Director
72,500$072,500
(Direct)
View

Ownership
2024-05-03
4:15 pm
N/A
2033-08-14
NewAmsterdam Pharma Co N.V.NAMSJONES WILLIAM A JR
Chief Commercial Officer
0$0945,598
(Direct)
View
2024-04-01
Option Award
2024-04-02
4:30 pm
N/A
2034-04-01
NewAmsterdam Pharma Co N.V.NAMSAudet Juliette Berangere
Chief Business Officer
250,000$0250,000
(Direct)
View
2024-03-26
Tax Withholding
2024-03-27
4:30 pm
N/A
N/A
NewAmsterdam Pharma Co N.V.NAMSKastelein Johannes Jacob Pieter
Chief Scientific Officer
11,197$22.72970,229
(Indirect)
View
2024-03-26
Exercise
2024-03-27
4:30 pm
N/A
2031-07-06
NewAmsterdam Pharma Co N.V.NAMSKastelein Johannes Jacob Pieter
Chief Scientific Officer
201,673$0970,229
(Indirect)
View

Ownership(A)
2024-01-25
5:00 pm
2022-12-22
2027-11-23
NewAmsterdam Pharma Co N.V.NAMSDavidson Michael H.
Chief Executive Officer
0$0100,000
(Direct)
View

Ownership(A)
2024-01-25
5:00 pm
N/A
N/A
NewAmsterdam Pharma Co N.V.NAMSLANGE LOUIS G
Director
0$0234,683
(Direct)
View
2024-01-04
Option Award
2024-01-08
7:43 pm
N/A
2034-01-04
NewAmsterdam Pharma Co N.V.NAMSLewis William
Director
100,000$0100,000
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:26 pm
N/A
2034-01-01
NewAmsterdam Pharma Co N.V.NAMSKooij Louise Frederika
Chief Accounting Officer
150,494$0150,494
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:21 pm
N/A
2034-01-01
NewAmsterdam Pharma Co N.V.NAMSKling Douglas F
Chief Operating Officer
323,771$0323,771
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:19 pm
N/A
2034-01-01
NewAmsterdam Pharma Co N.V.NAMSvan der Kamp Hilde Johanna
Director
10,000$010,000
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:17 pm
N/A
2034-01-01
NewAmsterdam Pharma Co N.V.NAMSLANGE LOUIS G
Director
10,000$010,000
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:17 pm
N/A
2034-01-01
NewAmsterdam Pharma Co N.V.NAMSKastelein Johannes Jacob Pieter
Chief Scientific Officer
500,000$0500,000
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:14 pm
N/A
2034-01-01
NewAmsterdam Pharma Co N.V.NAMSDavidson Michael H.
Chief Executive Officer
1,039,939$01,039,939
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:13 pm
N/A
2034-01-01
NewAmsterdam Pharma Co N.V.NAMSSmither John W
Director
10,000$010,000
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:10 pm
N/A
2034-01-01
NewAmsterdam Pharma Co N.V.NAMSSomaiya Mayur Ian
Chief Financial Officer
80,000$080,000
(Direct)
View

Ownership
2024-01-02
4:00 pm
N/A
N/A
NewAmsterdam Pharma Co N.V.NAMSForGrowth NAP B.V.
Forbion Capital Fund IV Cooperatief U.A.
Forbion IV Management B.V.
Forbion Growth Opportunities Fund I Cooperatief U.A.
Forbion Growth Management B.V.
10% Owner
0$011,831,461
(Indirect)
View

Ownership
2023-12-29
5:09 pm
N/A
N/A
NewAmsterdam Pharma Co N.V.NAMSBain Capital Life Sciences Investors LLC
BCLS Fund III Investments LP
Bain Capital Life Sciences III General Partner LLC
Bain Capital Life Sciences Fund III L.P.
BCLS Fund III Investments GP LLC
BCLS II Investco LP
BCLS II Investco (GP) LLC
Bain Capital Life Sciences Fund II L.P.
Bain Capital Life Sciences Investors II LLC
BCIP Life Sciences Associates LP
10% Owner
0$010,573,913
(Indirect)
View

Ownership
2023-12-29
4:30 pm
N/A
2033-01-14
NewAmsterdam Pharma Co N.V.NAMSSmither John W
Director
0$018,600
(Direct)
View

Ownership
2023-12-29
4:30 pm
N/A
N/A
NewAmsterdam Pharma Co N.V.NAMSTopper James N
Director
0$07,301,333
(Indirect)
View

Ownership
2023-12-29
4:30 pm
N/A
2033-01-01
NewAmsterdam Pharma Co N.V.NAMSKastelein Johannes Jacob Pieter
Chief Scientific Officer
0$02,620,975
(Direct)
View

Ownership
2023-12-29
4:30 pm
N/A
2033-01-01
NewAmsterdam Pharma Co N.V.NAMSKling Douglas F
Chief Operating Officer
0$01,378,172
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, Next